Regulation of collagenolytic activity using platelet preparations in vitro

Purpose: to study different platelet preparations' impact on collagenase activity in vitro. Materials and methods. Human amnion transplants and collagen covers, based on human type 1 collagen, were used as collagen matrices. The drug Fermencol was used as a source of collagen-lytic peptidases. We used platelet-rich plasma (PRP); concentrated suspension of platelets washed from plasma (WP); platelet-poor plasma (PPP); lysates of PRP, PPP and WP. To assess the collagen-lytic activity we studied the level of collagen autofluorescence in tissue grafts, collagen concentration in solution, proliferation intensity of mesenchymal multipotent stromal cells (MMSC) on the surface of the grafts. Results. Preparations based on PRP and WP stimulated significant inhibition of collagen-lytic activity, which was absent in PPP. The inhibition of collagen-lytic effect in PRP and WP depended on the initial content of platelets with granules. Platelet preparations significantly enhanced the adhesion and growth of MMSC on the surface of the amnion and collagen cover. Conclusion. The use of platelet lysates combined high inhibition of collagen-lytic peptidases and growth-stimulating effect, which persists even with dilution of PRP lysate in ratio 1:200. For effective inhibition of collagen-lytic peptidases is recommended to use PRP with initial concentration of platelets with granules at least 350 thousand/ml.

1. Anitua E, Zalduendo M, Troya M, Alkhraisat MH, Blanco-Antona LA. Platelet-rich plasma as an alternative to xenogeneic sera in cell-based therapies: A need for standardization. Int J Mol Sci. 2022; 23 (12): 6552. doi: 10.3390/ijms23126552

2. Henschler R, Gabriel C, Schallmoser K, Burnouf T, Koh MBC. Human platelet lysate current standards and future developments. Transfusion. 2019; 59: 1407–13. doi: 10.1111/trf.15174

3. Hargett LA, Bauer NN. On the origin of microparticles: From “platelet dust” to mediators of intercellular communication. Pulm Circ. 2013; 3 (2): 329–40. doi: 10.4103/2045-8932.114760

4. Jiang LB, Su DH, Liu P, et al. Shape-memory collagen scaffold for enhanced cartilage regeneration: native collagen versus denatured collagen. Osteoarthritis Cartilage. 2018; 26 (10): 1389–99. doi: 10.1016/j.joca.2018.06.004

5. Chentsova E.V., Borovkova N.V., Makarov P.V., et al. The biological effect of a combination of platelet lysate and amniotic membrane in buccal epithelium culture. Russian ophthalmological journal. 2022; 15 (4): 115–20. (In Russ.). https://doi.org/10.21516/2072-0076-2022-15-4-115-120

6. Villeneuve J, Block A, Le Bousse-Kerdil s MC, et al. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. Exp Hematol. 2009; 37 (7): 849–56. doi: 10.1016/j.exphem.2009.03.009

7. Nejad AR, Hamidieh AA, Amirkhani MA, Sisakht MM. Update review on five top clinical applications of human amniotic membrane in regenerative medicine. Placenta. 2021; 103: 104–19. doi: 10.1016/j.placenta.2020.10.026

8. Ermolov A.S., Smirnov S.V., Khvatov V.B., et al. Biological cover for burn wound treatment. Patent RF No 2314129; 2008 (In Russ.).

9. Borovkova N.V., Makarov M.S., Andreev Ju.V., Storozheva M.V., Ponomarev I.N. Evaluation of the cytokine composition of blood serum and preparations based on human platelets. Molekuljarnaja medicina. 2021; 19 (3): 51–7 (In Russ.). https://doi.org/10.29296/24999490-2021-03-08

10. Stepanchenko N.S., Novikova G.V., Moshkov I.E. Quantitative determination of protein content. Fiziologija rastenij. 2011, 58 (4): 624–30 (In Russ.).

11. Smirnov V.A., Klimochkin Yu.N. Amino acids and polypeptides: a tutorial. Part I. Samara. Samara State Technical University. 2007 (In Russ.).

12. Makarov M.S., Storozheva M.V., Borovkova N.V. Collagen fiber autofluorescence level in evaluating the biological properties of tissue grafts. Sovremennye tekhnologii v medicine 2017; 9 (2): 83–90 (In Russ.). https://doi.org/10.17691/stm2017.9.2.10